In the pancreatic cancer cell line BxPC-3, CHIP ubiquitinates and promotes the degradation of epidermal growth factor receptor (EGFR), and overexpression of CHIP suppresses cell growth [122] and is consistent with a tumor-suppressive role for CHIP in glioblastoma [130]. Here, EGFR is linked to pancreatic neoplasm.